In The News

• Jan 2026

  Denovicon Introduces its Physics-Driven AI Multi-Objective Optimization Platform

• Nov 2025

  Denovicon Renewed for the 3DEXPERIENCE Lab Accelerator

• Oct 2025

  Denovicon Therapeutics joins ARPA-H Investor Catalyst Hub Spoke Network

• May 2025

  Re-Inventing Drug Discovery

• Oct 2024

  Denovicon is Accepted into the 3DEXPERIENCE Lab Accelerator

• Apr 2023

  DRUG DISCOVERY CHEMISTRY CONFERENCE 2023

• Oct 2022

  Biovia User Group Meeting 2022

• Feb 2022

  Denovicon Founder to Present at SLAS 2022